EP Patent

EP0698398A1 — Blood collection device

Assigned to Becton Dickinson and Co · Expires 1996-02-28 · 30y expired

What this patent protects

A blood collection device comprising an anticoagulant formulation on the interior surface of the device. The anticoagulant formulation on the interior surface of the device is an improvement over available devices that contain liquid anticoagulant formulations. The device is coat…

USPTO Abstract

A blood collection device comprising an anticoagulant formulation on the interior surface of the device. The anticoagulant formulation on the interior surface of the device is an improvement over available devices that contain liquid anticoagulant formulations. The device is coated by combining sodium citrate and citric acid in a water vehicle, spraying the formulation onto the interior surface of the device, followed by air drying.

Drugs covered by this patent

Patent Metadata

Patent number
EP0698398A1
Jurisdiction
EP
Classification
Expires
1996-02-28
Drug substance claim
No
Drug product claim
No
Assignee
Becton Dickinson and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.